These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34745385)

  • 1. Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma.
    Guo H; Wang S; Xie A; Sun W; Wei C; Xian S; Yin H; Li M; Sun H; Li H; Meng T; Zhang J; Huang Z
    Dis Markers; 2021; 2021():1484227. PubMed ID: 34745385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme.
    Huang R; Li Z; Li C; Wang G; Yan P; Peng L; Wang J; Zhu X; Hu P; Zhang J; Chang Z; Huang Z; Cheng L; Zhang J
    Front Genet; 2019; 10():1380. PubMed ID: 32117422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of drug targets and prognosis projection for uterine carcinosarcoma based on alternative splicing events.
    Zhang X; Yin X; Zhang L; Ye Z; Liang G
    Comput Biol Med; 2023 Jan; 152():106346. PubMed ID: 36470146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma.
    Meng T; Huang R; Zeng Z; Huang Z; Yin H; Jiao C; Yan P; Hu P; Zhu X; Li Z; Song D; Zhang J; Cheng L
    Front Bioeng Biotechnol; 2019; 7():270. PubMed ID: 31681747
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
    Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Construction of Bone Metastasis-Specific Prognostic Model and Co-expressed Network of Alternative Splicing in Breast Cancer.
    Huang R; Guo J; Yan P; Zhai S; Hu P; Zhu X; Zhang J; Qiao Y; Zhang Y; Liu H; Huang L; Zhang J; Yang D; Huang Z
    Front Cell Dev Biol; 2020; 8():790. PubMed ID: 32984314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression Analysis of Genes and Tumor-Infiltrating Immune Cells in Metastatic Uterine Carcinosarcoma.
    Huang R; Sun H; Yan G; Zhang L; Sun W; Zhang J; Yin H; Xian S; Hu P; Yan P; Zhu X; Meng T; Wang J; Huang Z
    Reprod Sci; 2021 Sep; 28(9):2685-2698. PubMed ID: 33905082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
    Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
    Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma.
    An Y; Wang Q; Sun F; Zhang G; Wang F; Zhang L; Li Y; Ren W; Zhu W; Li Y; Ji S; Guo X
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma.
    Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z
    Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis of the prognostic role of alternative splicing data in lung adenocarcinoma.
    Zhao L; He S; Liu Z; Song Z; Hou X; Gai L
    J Thorac Dis; 2024 Feb; 16(2):1463-1472. PubMed ID: 38505068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
    Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
    J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line.
    Stockhammer P; Okumus Ö; Hegedus L; Rittler D; Ploenes T; Herold T; Kalbourtzis S; Bankfalvi A; Sucker A; Kimmig R; Aigner C; Hegedus B
    Pathol Oncol Res; 2021; 27():636088. PubMed ID: 34257602
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer.
    Huang R; Zheng Z; Xian S; Zhang J; Jia J; Song D; Yan P; Yin H; Hu P; Zhu X; Huang Z; Meng T; Zhang J
    Bioengineered; 2021 Dec; 12(1):5289-5304. PubMed ID: 34402716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
    Lai J; Yang H; Xu T
    BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.
    Zhang D; Zou D; Deng Y; Yang L
    J Ovarian Res; 2021 Sep; 14(1):120. PubMed ID: 34526089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine Carcinosarcoma.
    Mi S; Lin M; Brouwer-Visser J; Heim J; Smotkin D; Hebert T; Gunter MJ; Goldberg GL; Zheng D; Huang GS
    Clin Cancer Res; 2016 Sep; 22(18):4676-86. PubMed ID: 27121792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-mediated motility receptor expression functions as a prognostic biomarker in uterine carcinosarcoma based on bioinformatics analysis.
    Sun H; Ma L; Chen J
    J Int Med Res; 2021 Jun; 49(6):3000605211021043. PubMed ID: 34111996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
    Etoh T; Nakai H
    J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer.
    Shao XY; Dong J; Zhang H; Wu YS; Zheng L
    Front Genet; 2020; 11():726. PubMed ID: 32793282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.